Townsend & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$2.19M |
| 2 |
International Flavors & Fragrances
IFF
|
+$2.07M |
| 3 |
Cracker Barrel
CBRL
|
+$2.05M |
| 4 |
Illinois Tool Works
ITW
|
+$2M |
| 5 |
Realty Income
O
|
+$1.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Motorola Solutions
MSI
|
+$2.33M |
| 2 |
OGE Energy
OGE
|
+$2.25M |
| 3 |
W.P. Carey
WPC
|
+$2.21M |
| 4 |
Johnson Controls International
JCI
|
+$1.97M |
| 5 |
BRSL
Brightstar Lottery PLC
BRSL
|
+$1.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.83% |
| 2 | Consumer Discretionary | 13.47% |
| 3 | Healthcare | 10.33% |
| 4 | Consumer Staples | 10.03% |
| 5 | Financials | 8.71% |
Similar funds
Townsend & Associates's Q3 2018 Portfolio in Review
As of Q3 2018, Townsend & Associates held 172 positions worth $101M, up 13% from $89.1M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Townsend & Associates deployed $6.78M of net new capital in Q3 2018, opening 13 new positions and adding to 88 existing holdings. Its largest new stake was CVS Health: 30,641 shares worth $2.41M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Motorola Solutions, an estimated $2.33M trimmed.
- Townsend & Associates's largest Q3 2018 buy was CVS Health: 30,641 shares worth $2.41M.
- Townsend & Associates added most to Illinois Tool Works in Q3 2018, an estimated $2M increase.
- Townsend & Associates's biggest Q3 2018 reduction was Motorola Solutions, cutting an estimated $2.33M.
- Townsend & Associates fully exited OGE Energy in Q3 2018, selling an estimated $2.25M.
- Townsend & Associates's ten largest holdings make up 26% of its $101M portfolio in Q3 2018.
- Townsend & Associates opened 13 new positions and closed 13 in Q3 2018.
- Townsend & Associates's portfolio value rose 13% quarter-over-quarter to $101M.
Based on Townsend & Associates's 13F filing for Q3 2018, filed 29 Oct 2018.